Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shijiazhuang Yiling Pharmaceutical Co. Ltd

Clinical trials sponsored by Shijiazhuang Yiling Pharmaceutical Co. Ltd, explained in plain language.

Shijiazhuang Yiling Pharmaceutical Co. Ltd 002603 SZSE

A Chinese pharmaceutical company focused on traditional Chinese medicine and innovative drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New leukemia drug candidate undergoes heart safety check

Knowledge-focused Recruiting now

This early-stage trial is testing whether a single dose of XY0206 tablets affects the heart's electrical activity (QTc interval) in 45 healthy Chinese adults. Participants are randomly assigned to receive XY0206, a placebo, or an active control (moxifloxacin). The study lasts 3 d…

Phase: PHASE1 • Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd • Aim: Knowledge-focused

Last updated Jun 26, 2026 15:01 UTC